Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CHEMEX PRODUCTS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9%   Bankruptcy risk   1.2% 1.5% 3.1% 2.3% 1.3% 1.0% 11.6% 8.9%   Credit score (0-100)   83 79 58 65 79 86 20 28   Credit rating   A A BBB BBB A A BB BB   Credit limit (kDKK)   258.3 67.4 0.0 0.2 165.2 648.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,693 4,796 2,304 2,091 3,318 3,507 0.0 0.0   EBITDA   330 1,277 95.1 -158 1,115 1,309 0.0 0.0   EBIT   328 1,274 92.1 -161 1,112 1,308 0.0 0.0   Pre-tax profit (PTP)   778.7 1,320.7 -152.0 222.7 1,564.4 1,621.5 0.0 0.0   Net earnings   752.3 1,078.9 -146.3 268.6 1,332.3 1,354.5 0.0 0.0   Pre-tax profit without non-rec. items   779 1,321 -152 223 1,564 1,621 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   13.1 10.1 7.1 4.0 1.0 0.0 0.0 0.0   Shareholders equity total   10,261 11,317 10,415 10,648 10,476 10,789 2,846 2,846   Interest-bearing liabilities   0.0 1,319 156 0.0 1,594 4,087 0.0 0.0   Balance sheet total (assets)   16,228 22,831 13,224 18,683 18,253 19,149 2,846 2,846   Net Debt   -448 658 -48.4 -4,375 1,383 2,914 -2,846 -2,846     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,693 4,796 2,304 2,091 3,318 3,507 0.0 0.0   Gross profit growth   -0.7% 29.9% -52.0% -9.2% 58.6% 5.7% -100.0% 0.0%   Employees   6 6 4 4 4 4 0 0   Employee growth %   0.0% 0.0% -33.3% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   16,228 22,831 13,224 18,683 18,253 19,149 2,846 2,846   Balance sheet change%   30.1% 40.7% -42.1% 41.3% -2.3% 4.9% -85.1% 0.0%   Added value   330.1 1,276.7 95.1 -158.4 1,115.3 1,309.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   11 -6 -6 -6 -6 -2 -0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.9% 26.6% 4.0% -7.7% 33.5% 37.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.9% 7.7% -0.2% 1.7% 8.8% 9.2% 0.0% 0.0%   ROI %   10.0% 13.1% -0.3% 2.6% 14.4% 12.8% 0.0% 0.0%   ROE %   7.6% 10.0% -1.3% 2.6% 12.6% 12.7% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   63.2% 49.6% 78.8% 57.0% 57.4% 56.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -135.7% 51.6% -50.9% 2,762.3% 124.0% 222.6% 0.0% 0.0%   Gearing %   0.0% 11.7% 1.5% 0.0% 15.2% 37.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 26.7% 16.0% 61.6% 8.3% 3.4% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.7 1.4 3.4 1.5 1.9 1.9 0.0 0.0   Current Ratio   2.5 1.9 4.6 2.3 2.2 2.2 0.0 0.0   Cash and cash equivalent   448.0 660.4 204.2 4,375.0 210.6 1,172.7 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9,037.3 10,325.4 9,857.4 9,953.8 9,420.3 9,880.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   55 213 24 -40 279 327 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   55 213 24 -40 279 327 0 0   EBIT / employee   55 212 23 -40 278 327 0 0   Net earnings / employee   125 180 -37 67 333 339 0 0